Radovan Vrhovac

9PUBLICATIONS
63CO-AUTHORS
HaematologyRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAudiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 17, 2026
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.

|May 27, 2026
Early Peripheral Blood WT1 Expression Predicts Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.

|May 19, 2026
Von Willebrand factor and factor VIII as potential biomarkers for diagnosis and disease monitoring in chronic graft-versus-host disease.

|Nov 18, 2025
G-CSF Priming of Haploidentical Bone Marrow: Effects on Cell Yield, Collection Efficiency, and Tolerogenic Graft Composition.

Nadira Duraković, Antonija Babić, Lana Desnica

|Sep 05, 2025
Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model.

Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux

|Jun 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.

Guillaume Dachy, Myriam Labopin, Gérard Socié

Pageof 2

Frequent Collaborators

3 joint publications

Mohamad Mohty

2 joint publications

Fabio Ciceri

2 joint publications

Myriam Labopin

2 joint publications

Didier Blaise